The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 29, 2019
Filed:
Dec. 18, 2015
Applicant:
Galderma Research & Development, Biot, FR;
Inventors:
Branislav Musicki, Nice, FR;
Claire Bouix-Peter, Vallauris, FR;
Gilles Ouvry, Biot, FR;
Etienne Thoreau, Saint Vallier de Thiey, FR;
Assignee:
GALDERMA RESEARCH & DEVELOPMENT, Biot, FR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/29 (2006.01); C07D 417/06 (2006.01); C07D 309/06 (2006.01); C07D 309/04 (2006.01); C07D 307/93 (2006.01); C07D 261/08 (2006.01); C07D 211/22 (2006.01); C07D 211/46 (2006.01); C07D 213/30 (2006.01); C07D 279/16 (2006.01); C07D 305/06 (2006.01); C07D 305/08 (2006.01); C07D 335/02 (2006.01); C07D 309/12 (2006.01); C07D 333/48 (2006.01); C07D 207/26 (2006.01); C07D 309/08 (2006.01); C07D 263/20 (2006.01); C07D 263/24 (2006.01); C07D 271/08 (2006.01); C07D 295/096 (2006.01); C07D 211/76 (2006.01); C07D 211/96 (2006.01); C07C 381/10 (2006.01); A61P 17/10 (2006.01);
U.S. Cl.
CPC ...
C07D 207/26 (2013.01); A61P 17/10 (2018.01); C07C 311/29 (2013.01); C07C 381/10 (2013.01); C07D 211/22 (2013.01); C07D 211/46 (2013.01); C07D 211/76 (2013.01); C07D 211/96 (2013.01); C07D 213/30 (2013.01); C07D 261/08 (2013.01); C07D 263/20 (2013.01); C07D 263/24 (2013.01); C07D 271/08 (2013.01); C07D 279/16 (2013.01); C07D 295/096 (2013.01); C07D 305/06 (2013.01); C07D 305/08 (2013.01); C07D 307/93 (2013.01); C07D 309/04 (2013.01); C07D 309/06 (2013.01); C07D 309/08 (2013.01); C07D 309/12 (2013.01); C07D 333/48 (2013.01); C07D 335/02 (2013.01); C07D 417/06 (2013.01);
Abstract
Benzenesulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonist of retinoid-related orphan receptor gamma (RORγt) are described. A pharmaceutical composition including such compounds, as well as the use thereof for the topical and/or oral treatment of RORγt receptor-medicated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis are also described.